Long-acting GLP-1 receptor agonist with an IgG4-Fc fusion for extended half-life. Weekly dosing provides sustained appetite suppression and glycemic control. FDA-approved for type 2 diabetes with cardiovascular benefits.
Inject SubQ once weekly, same day each week. Titrate: 0.75mg x4wk → 1.5mg x4wk → 3mg x4wk → 4.5mg. Any time of day, with or without food.
Log doses, calculate reconstitution, set reminders, and get AI guidance for Dulaglutide.
Start Free Trial